Article
Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.
Journal of neurochemistry - 1 Apr 2016
Hannan Shabab B, Dräger Nina M, Rasse Tobias M, Voigt Aaron, Jahn Thomas R
Abstract excerpt
Abnormal tau accumulations were observed and documented in post-mortem brains of patients affected by Alzheimer's disease (AD) long before the identification of mutations in the Microtubule-associated protein tau (MAPT) gene, encoding the tau protein, in a different neurodegenerative disease called Frontotemporal dementia and Parkinsonism linked to chromosome 17 (FTDP-17). The discovery of mutations in the MAPT...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
